Arcturus Therapeutics — 24 certified H-1B filings (FY2016–FY2026)

3
Filings · FY2025
$190k
Median base · FY2025
Scientist I
Top role · 6 all-time
CA
Top state · 24 all-time
FY

Arcturus Therapeutics filed 3 certified H-1B LCAs in FY2025 (up 50% from the year before), with a median base salary of $190k and the middle 50% of offers between $158k and $2.6M. That is 15% above the market median for the same job titles. Across all years it has 24 certified filings since FY2016, most often for Scientist I in California.

How much does Arcturus Therapeutics pay H-1B workers?

Certified base salary by fiscal year: each box is the p25–p75 range, the heavy line the median, the whiskers reach p10–p90. $190k median in FY2025. Base pay only — hover a year for its figures.

$-200000$0$200k$400k$600k$800k$1000k$1200k$1400k$1600k$1800k$2000k$2200k$2400k$2600k$2800k’16’18’19’20’21’22’23’24’25’26

How has Arcturus Therapeutics's H-1B hiring changed by year?

1 certified filings in FY2016 → 1 in FY2026. The change column is each year against the one before.

Arcturus Therapeutics certified H-1B filings and base salary by fiscal year
Fiscal yearFilingsvs prior FYMedian base
FY20261−67%$158k
FY20253+50%$190k
FY202420%$134k
FY20232+100%$120k
FY20221−83%$129k
FY20216+100%$93k
FY20203−25%$92k
FY20194+300%$57k
FY201810%$158k
FY20161—$75k

Which wage levels does Arcturus Therapeutics file?

DOL prevailing-wage levels I–IV approximate experience tiers (I = entry, IV = fully competent). 43% of Arcturus Therapeutics's filings sit at Level III–IV. A heavy I–II skew reads as entry-level or contractor-style hiring; a heavy IV skew as senior in-house roles — and higher levels earn more lottery entries.

Share of 23 filings with a wage level · all years

26%
30%
43%
  • Level I26.1%6
  • Level II30.4%7
  • Level IV43.5%10

What jobs does Arcturus Therapeutics sponsor for H-1B?

The most-filed job titles across all years (DOL titles, employer pay-grade codes stripped), with base-salary percentiles.

Arcturus Therapeutics most-sponsored H-1B job titles with base-salary percentiles
Job titleFilingsMedian base
Scientist I6$92k
Senior Scientist2$134k
Associate Director of External Manufacturing2$129k
Senior Manager, Technical Services2$125k
Senior Scientist II1$158k
Analytical Scientist1$75k
Associate Director, Stability1$159k
Director of Quality and Regulatory Affairs1$158k
Director, External Manufacturing & Supply1$190k
Research Assoc Rna Molecular Bio (Frontier Sci - 19-1029.02)1$57k

Where does Arcturus Therapeutics hire H-1B workers?

Worksite states on the certified filings, all years. Deeper pink = more filings; hover a state for its figures.

2424Certified filings (log scale)
Arcturus Therapeutics H-1B worksite states
StateFilingsMedian base
CA24$120k

What has Arcturus Therapeutics filed recently?

Every certified LCA on record for Arcturus Therapeutics: job title, worksite, prevailing-wage level and the offered base salary.

Arcturus Therapeutics recent certified H-1B LCA filings
FYJob titleBase salary
2026Senior Scientist II$158,300
2025Senior Research Associate I$2,574,208
2025Director, External Manufacturing & Supply$190,000
2025Associate Director of External Manufacturing$158,300
2024Associate Director, Stability$159,432
2024Senior Scientist$134,000
2023Senior Scientist$134,000
2023Scientist I$119,600
2022Associate Director of External Manufacturing$129,000
2021Senior Manager, Stability$155,000
2021Scientist I$93,000
2021Senior Manager, Technical Services$125,000
2021Scientist I$93,000
2021Research Associate II$74,850
2021Senior Manager, Technical Services$125,000
2020Scientist I$91,746
2020Scientist I$91,746
2020Scientist I$91,755
2019Research Associate II - Frontier Science (19-1029.02)$71,531
2019Senior Engineer, Technical Transfer$98,000
2019Research Assoc Rna Molecular Bio (Frontier Sci - 19-1029.02)$56,805
2019Research Associate I (Formulations Development)$56,805
2018Director of Quality and Regulatory Affairs$158,496
2016Analytical Scientist$74,880

Common questions about Arcturus Therapeutics's H-1B filings

How much does Arcturus Therapeutics pay H-1B workers?
Arcturus Therapeutics's median certified H-1B base salary is $190k (FY2025), from 3 filings. See the full salary distribution and percentiles above.
How many H-1B workers does Arcturus Therapeutics sponsor?
Arcturus Therapeutics has 24 certified H-1B Labor Condition Applications on record (FY2016–FY2026).
What jobs does Arcturus Therapeutics sponsor for H-1B?
Arcturus Therapeutics's most-sponsored H-1B roles include Scientist I, Senior Scientist, Associate Director of External Manufacturing, Senior Manager, Technical Services.
Where does Arcturus Therapeutics hire H-1B workers?
Arcturus Therapeutics's top H-1B worksite states are CA.
Does a certified LCA mean an H-1B visa was approved?
No. A Labor Condition Application (LCA) is the Department of Labor attestation an employer must have certified before filing an H-1B petition with USCIS. It records the job, worksite and offered wage, but not whether the petition was filed, selected in the lottery, or approved. Filing counts measure intent to sponsor, not headcount.
What salary do these figures show?
The base annual wage offered on the certified LCA, converted to a yearly amount. Bonus, equity, overtime and benefits are not included, so total compensation is typically higher. Figures are medians and percentiles over certified filings; wages above $5,000,000 a year are excluded as data-entry errors.
What do prevailing-wage levels I–IV mean?
The Department of Labor assigns each LCA an OES wage level from I (entry) to IV (fully competent) for the occupation and area. Under the FY2027 wage-weighted H-1B lottery rule, a higher level earns more selection entries, so an employer's level mix is a proxy for how senior its sponsored roles are.

Keep exploring

Browse all sponsors →

Calculate your H-1B lottery odds →orCheck out the insights →

Source: U.S. Department of Labor, Office of Foreign Labor Certification — certified LCA disclosure data through June 2026 (FY2016–FY2026). An LCA is not an approved visa; pay figures are base salary and exclude bonus and equity. Methodology →